학술논문

Paired phase II trials evaluating cetuximab and radiotherapy for low risk HPV associated oropharyngeal cancer and locoregionally advanced squamous cell carcinoma of the head and neck in patients not eligible for cisplatin.
Document Type
Article
Source
Head & Neck; Aug2020, Vol. 42 Issue 8, p1728-1737, 10p
Subject
OROPHARYNGEAL cancer
SQUAMOUS cell carcinoma
PROGRESSION-free survival
PAPILLOMAVIRUSES
RADIOTHERAPY
Language
ISSN
10433074
Abstract
Copyright of Head & Neck is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)